You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/68320
Title: 
Testes de biocompatibilidade in vitro de duas formas comerciais do agregado de trióxido mineral
Other Titles: 
In vitro biocompatibility tests of two commercial types of mineral trioxide aggregate
Author(s): 
Institution: 
  • Universidade Estadual Paulista (UNESP)
  • University of Sacred Heart
ISSN: 
  • 1806-8324
  • 1807-3107
Abstract: 
Recently, regular and white mineral trioxide aggregate (MTA) are being used in Dentistry as retrofilling materials. Genotoxicity and cytotoxicity tests form an important part of cancer research and risk assessment of potential carcinogens. Thus, the goal of this study was to examine the genotoxicity and cytotoxicity of regular and white MTA in vitro by the single cell gel (comet) assay and trypan blue exclusion test, respectively. Mouse lymphoma cells were exposed to two presentation forms of MTA at final concentrations ranging from 1 to 1,000 μg/mL for 3 h at 37°C. The results showed that both compounds tested did not produce genotoxic effects at all concentrations evaluated. Likewise, no statistically significant differences (p > 0.05) were observed in cytotoxicity. Taken together, our results suggest that regular and white MTA are not genotoxins and are not able to interfere in cellular viability as assessed by single cell gel (comet) assay and trypan blue assay, respectively.
Issue Date: 
1-Jul-2005
Citation: 
Brazilian Oral Research, v. 19, n. 3, p. 183-187, 2005.
Time Duration: 
183-187
Keywords: 
  • Comet assay
  • Genotoxicity tests
  • Mineral trioxide aggregate
  • Mouse lymphoma cells
  • Trypan blue
Source: 
http://dx.doi.org/10.1590/S1806-83242005000300005
URI: 
Access Rights: 
Acesso aberto
Type: 
outro
Source:
http://repositorio.unesp.br/handle/11449/68320
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.